InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by SCHWARTZ BRIAN, Director. Officer active across 2 companies, notably Cyclacel Pharmaceuticals, Inc.. Aggregated, 4 filings have been recorded. The latest transaction was filed on 14 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
€19,90530,919 shares@ €0.6438100.0% of flow
Common Stock
SEC:0001140361-22-023308:0·
015,822 shares0
Common Stock
SEC:0001104659-22-071895:0·
02,374 shares0
Common Stock
SEC:0001104659-21-082597·
02,374 shares0
Common Stock
SEC:0001104659-21-082597:0·
4 of 4 declarations
About SCHWARTZ BRIAN
Brian Schwartz is a Board Member at Cyclacel Pharmaceuticals, Inc. and INFINITY PHARMACEUTICALS, INC. In these roles, he contributes to the governance of the companies and strategic decision-making. His experience in the pharmaceutical sector allows him to bring valuable insights to help guide development and innovation strategies.
